Is Labiaplasty Right for You? A Guide to Costs, Benefits, and Realistic Expectations
Cellfina was once a widely used, FDA-cleared cellulite treatment that focused on releasing the connective bands (fibrous septae) beneath the skin that cause dimpling. While it provided long-lasting results for many, the device has been discontinued nationally and is no longer available at our practice or anywhere in the U.S.
Currently, Avéli has become the preferred option for targeted cellulite reduction. This updated technology provides a precise, single-treatment approach to address the same underlying structural causes of cellulite, offering improved control and real-time confirmation during the procedure
While both Cellfina and Avéli targeted the fibrous bands causing dimples, Avéli provides a more streamlined experience with real-time confirmation of each band release. Here's how they compare:
Even though it’s no longer in use, Cellfina earned its reputation for good reason. It was the first FDA-cleared treatment shown to improve the appearance of cellulite for up to three years in clinical trials. For many patients, it offered a visible improvement in dimpling with a single, minimally invasive treatment.
Patients liked that:
If you're researching cellulite treatments and came across Cellfina, know that Avéli is the modern evolution of the same treatment concept. It targets the same structural issues beneath the skin, but with greater accuracy, reduced bruising, and immediate confirmation that each band has been successfully treated.
One of the key benefits of Avéli is that it typically requires just 1–2 small entry points, no matter how many dimples are treated. In contrast, Cellfina required a separate entry point for each dimple. This advancement means fewer punctures, less potential for scarring, and a smoother recovery, especially important for patients with darker skin types who are more prone to post-inflammatory hyperpigmentation.
Another major difference is that Avéli can treat certain types of linear cellulite depressions, particularly on the thighs, something Cellfina wasn’t designed to do. That means Avéli may be a more comprehensive solution for patients who have both dimples and line-like indentations, offering smoother skin across more areas of concern.
Cellfina was discontinued by its manufacturer for commercial reasons. It is no longer available in the U.S. and has been phased out by most practices, including ours.
Yes. Avéli treats the same fibrous bands responsible for cellulite, but with more precision and a less invasive device. It builds upon Cellfina's concept with updated technology.
No. Since the device is no longer manufactured or supported, Cellfina is not currently available from any legitimate medical practice in the U.S.
Currently, Avéli is considered one of the most effective treatments for cellulite. It provides real-time confirmation during the procedure and is backed by clinical data.
While Cellfina had its time, technology continues to move forward. If you're interested in reducing cellulite with a safe, proven approach, our team would be happy to tell you more about Avéli and what kind of results you can expect. Schedule your consultation today to find out if you're a candidate.
📍 Located in Beverly Hills | 📞 Call (310) 773-3039
